Novartis to cut 220 jobs as it closes German site
Finance

Novartis to cut 220 jobs as it closes German site

Published by Global Banking & Finance Review

Posted on May 5, 2026

1 min read

· Last updated: May 5, 2026

Add as preferred source on Google

Novartis to Cut 220 Jobs Amid Wehr, Germany Production Site Closure

Novartis Announces Workforce Reduction and Site Closure

Details of the Job Cuts

May 5 (Reuters) - Swiss drugmaker Novartis said on Tuesday that it is set to cut around 220 jobs in Germany as part of the planned closure of a production site by the end of 2028.

Reasons Behind the Closure

The production site in Wehr, Germany, which manufactured tablets and capsules, is no longer competitive, the Swiss company said in a statement.

Reporting and Sources

(Reporting by Marleen Kaesebier)

Key Takeaways

  • Novartis will close its Wehr production site—making tablets and capsules—by end of 2028, affecting ~220 jobs (novartis.com)
  • The site is no longer competitive; however, Novartis asserts patient supply won’t be disrupted and it remains committed to Germany (novartis.com)
  • Meanwhile Novartis is investing €35 million in a new radioligand therapy production facility in Halle, Saxony‑Anhalt, expected to become operational in 2027 (novartis.com)

References

Frequently Asked Questions

Why is Novartis closing its production site in Wehr, Germany?
Novartis stated that the production site is no longer competitive, prompting its closure.
How many jobs will be affected by the Novartis site closure?
Around 220 jobs in Germany will be cut as a result of the closure.
What did the Wehr site manufacture?
The Wehr facility was responsible for manufacturing tablets and capsules.
When will the Novartis Wehr site close?
The production site is set to close by the end of 2028.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category